An assessment of counseling quality provided by community pharmacies to type 2 diabetic adult patients for oral therapy: a simulated patient study from Pakistan

Endocr J. 2019 Mar 28;66(3):233-239. doi: 10.1507/endocrj.EJ18-0429. Epub 2019 Feb 5.

Abstract

This study was conducted to assess quality of counseling provided to type 2 diabetic patients. For this cross-sectional study, a simulated patient method was applied in 562 selected community pharmacies of Punjab, Pakistan. A scenario for the metformin oral therapy was developed that illustrates direct counseling for adult diabetic patients. Counseling and communication skills were also assessed. Descriptive statistics and chi-square tests were used for analysis. Only 29.4% of simulated patients received medication counseling directly; 47.6% received it on request. About 32.8% of clients were referred to a physician without counseling. The most frequently provided information was dietary instruction (94.8%) and dose of therapy (84.5%). Only one quarter (25.3%) of simulated patients were asked about disease duration and similar rate (25.0%) was found for discussions of special warnings. The side effects, drug storage, drug-drug interactions and duration of therapy were ignored. Minimal information was provided about other medication during therapy (0.2%) and effect of medicine withdrawal (2.7%). About 59.5% simulated patients were instructed for compliance to medication. Counseling to type 2 diabetic patients in Pakistani community pharmacies is not very satisfactory. Pharmacies' staff have little focus on counseling. Professional training of staff could improve counseling and communication skills.

Keywords: Community pharmacies; Counseling; Metformin; Pakistan; Type 2 diabetic patients.

MeSH terms

  • Adult
  • Counseling / standards*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Health Care Surveys
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Pakistan
  • Pharmacies / standards*
  • Quality of Health Care

Substances

  • Hypoglycemic Agents